NYSE: AMRZ

Amrize (AMRZ) Stock Analysis & Forecast

Nov 13 close

$40.89+0.06 (+0.1%)

Gekko Brief

AI summaryNov 9 close

Amrize's week centers on a lowered 2026 outlook, with the company citing adverse weather, elevated interest rates and cost inflation weighing on construction markets, alongside Q3 results that showed revenue growth of 2.2%, net income of $558 million (up 3.3%), adjusted EBITDA of $1.1 billion and diluted EPS of $1.02, with Building Materials margins expanding 30 basis points. Building Envelope saw strong commercial roofing demand offset by weak residential markets, and the company completed its $1 billion share repurchase program while declaring a quarterly dividend. Berenberg has since downgraded Amrize from "Buy" to "Hold," setting a new price target of $46.00.

Shares closed at $42.82, up 2.3%, sitting between the 50-day moving average of $39.48 and the 200-day average of $50.21, with a one-month return of 18.3% but a six-month return of -17.7%. The GekkoIndex reads 51, placing the stock in the Neutral zone, and the price remains 22.2% below Gekko Fair Value of $55.05.

The next earnings date falls on 16 February 2027, outside a typical 20-trading-day hold. Over the past 90 days, insiders made 14 open-market purchases totaling $2,578,655, and two billionaire holders and two trailblazer holders are recorded. Analyst consensus across 17 firms includes 7 buy, 9 hold and 1 sell ratings, with a consensus target of $45.12.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Amrize price vs fair value

$52.83$40.89Nov ’25May ’26Nov ’26
Close $40.89200-day averageGekko Fair Value $52.83

Amrize quick facts

Market cap
$22.36B
P/E ratio
18.3
Forward P/E
15.5
EPS, TTM
$2.23
Revenue, TTM
$12.26B
Profit margin
10.2%
Dividend yield
1.06%
Beta
—
Volume
2.03M avg 4.36M
1-year return
−18.3%
Typical daily move
±3.8%
Typical 20-day move
±6.4%
50-day average
$39.32
200-day average
$49.96
Next earnings
Feb 16
Shares outstanding
532.4M
52-week range
$35.78$65.94

Amrize swing-trade checklist

Amrize scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive2 mixed0 headwinds

  • Trendmixed

    Averages disagree

    Close $40.89 sits between the 50-day ($39.32) and 200-day ($49.96) averages, or the averages disagree.

    See the chart
  • GekkoIndexmixed

    57.2, Neutral

    Reading 57.2 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuesupportive

    22.6% below

    Price is 22.6% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneysupportive

    Leans bullish

    Last 90 days: 8 open-market insider purchases.

    See smart money
  • Earnings risksupportive

    Reports in 93 days

    Next report Feb 16, 2027, 93 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalityno data

    No data

    Not enough years of history for a seasonal read.

A description of current data, not a recommendation. How this page works

Amrize stock chart and price history

Amrize closed at $40.89 on Nov 13, 2026, −18.3% over the past year, inside a 52-week range of $35.78 to $65.94.

Close50-day average200-day averageVolume
Amrize share price, past year, with 50-day and 200-day moving averages and volume$50$60DecJan 2026FebMarAprMayJunJulAugSepOctNov40.89

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+9.6%
3 months
−10.6%
6 months
−16.6%
1 year
−18.3%
The full AMRZ chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open AMRZ in Gekko

Follow Amrize through every session

Put AMRZ on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track AMRZ in GekkoFree for 7 days. No credit card required.

About Amrize

Amrize supplies building materials and systems used in infrastructure, commercial, and residential construction across North America and Canada. It is best known for products that range from cement and aggregates to roofing and wall systems used in building exteriors.

The company operates through two segments. Its Building Materials segment supplies cement, aggregates, ready-mix concrete, asphalt, and related construction materials, while its Building Envelope segment focuses on roofing and wall systems, covering single-ply membranes, insulation, shingles, sheathing, waterproofing, protective coatings, and adhesives, tapes, and sealants. Together these segments serve construction markets that span infrastructure, commercial, and residential building projects.

Amrize was incorporated in 2023 and is based in Zug, Switzerland, having previously operated under the name Holcim North America Finance Ltd before adopting its current name. Its shares are listed on the NYSE under the ticker AMRZ.

Listed
NYSE
Sector
Non-energy minerals
Industry
Construction materials
Website
amrize.com

Amrize GekkoIndex: the smart money zone

Amrize’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57.2, in the Neutral zone, up 5.5 points over five sessions.

010057.2Neutral

Up 5.5 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying22+0.8%+0.7%+3.1%+7.9%
Accumulation138+0.5%+0.5%+0.1%−3.9%
Neutral (current zone)169−0.7%−0.9%−1.9%−3.2%
Distribution14−1.0%−4.6%−9.7%−7.5%
Selling0Not available

Average AMRZ share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the AMRZ price, zone by zone.Track AMRZ in Gekko

Is Amrize stock overvalued? Gekko Fair Value

Amrize trades 22.6% below Gekko Fair Value of $52.83, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Amrize shares are worth, recalculated every trading day.

$52.83

Gekko Fair Value, Nov 14, 2026

22.6% Undervalued

At the end of Aug 2026 the price was 30.6% below the estimate.

Gekko Fair ValueShare price, month end
$53$41Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open AMRZ in Gekko

Amrize insider and Congress trading

Insiders filed 8 open-market purchases in Amrize worth $1.76M, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

$1.76Min 8 open-market purchases

FiledInsiderTypeSharesValue
Sep 3Jenisch Jan Philipp
director, officer: Chairman & CEO
Purchase15,000$638K
Sep 3Jenisch Jan Philipp
director, officer: Chairman & CEO
Purchase10,000$424K
Sep 3Jenisch Jan Philipp
director, officer: Chairman & CEO
Purchase2,000$85K
Sep 3Jenisch Jan Philipp
director, officer: Chairman & CEO
Purchase2,000$85K
Aug 26Singleton Denise R
officer: Chief Legal Officer & Corp Sec
Purchase3,500$154K

From Form 4 filings, dated to when each was filed.

Congress trades last 90 days

No trades in AMRZ were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for AMRZ, plotted on the chart in Gekko.Open AMRZ in Gekko

Buybacks

Amrize has been buying back its own shares.

Latest authorization
$1.00B, Oct 28, 2026
Bought back, quarter ended Sep 30, 2026
$572.0M
As a share of market cap
2.56%

From company filings.

Hedge funds and billionaires quarter ended Sep 30

2of the funds Gekko tracks hold AMRZ.

0added2opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko

Amrize earnings: next date and track record

Amrize reports on Feb 16, 2027 (93 days away), and beat the EPS estimate in 0 of its last 8 reports.

0 of 8reports beat the EPS estimate
±7.2%average move across the report
3 of 6reports followed by a gain

Share-price move across each report

−7.1%Aug ’25+6.0%Oct ’25+8.3%Feb ’26−6.4%Apr ’26−11.8%Aug ’26+3.4%Oct ’26

Last earnings call, Oct 28, 2026 AI summary

What they said
Amrize reported Q3 2026 revenue growth of 2.2%, net income of $558 million (up 3.3%), adjusted EBITDA of $1.1 billion, and diluted EPS of $1.02 (up 4.1%). Building Materials margins expanded 30 basis points driven by cement and aggregates pricing and ASPIRE savings program. Building Envelope saw strong commercial roofing demand offset by weak residential markets. The company completed its $1 billion share repurchase and deployed $262 million in CapEx.
Guidance
Management expects continued strong long-term demand from data centers, advanced manufacturing, and energy projects. Infrastructure funding extension and the proposed BUILD America 250 Act are expected to provide near-term and long-term tailwinds for cement and aggregates demand.
ReportedEPSSurpriseRevenueSurpriseMove
Oct 28, 2026$1.02
est $1.03
−1.0%$3.77B
est $3.83B
−1.5%+3.4%
Aug 6, 2026$0.88
est $0.92
−4.3%$3.49B
est $3.37B
+3.8%−11.8%
Apr 29, 2026−$0.16
est −$0.13
−18.7%$2.18B
est $2.13B
+2.4%−6.4%
Feb 17, 2026$0.54
est $0.65
−16.4%$2.84B
est $2.92B
−2.8%+8.3%
Oct 28, 2025$0.98
est $1.02
−3.9%$3.68B
est $3.49B
+5.4%+6.0%
Aug 6, 2025$0.78
est $1.03
−24.3%$3.22B
est $3.39B
−5.0%−7.1%
Jun 2, 2025−$0.10
est $1.15
−108.7%$2.08B
est $3.39B
−38.6%—
May 7, 2025−$0.14
est −$0.06
−127.5%$2.08B
est $2.08B
0.0%—

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Amrize stock forecast and analyst price targets

Analysts’ average 12-month price target for Amrize is $45.02, +10.1% from the last close, from 16 firms rating the stock in the last 90 days.

$45.02consensus 12-month target, +10.1% from the last close
Low $32High $60
Buy6
Hold9
Sell1

Each firm’s latest rating in the last 90 days: 16 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 12BarclaysHold, maintained$40−2.2%
Nov 9Berenberg BankHold, downgraded$46+12.5%
Nov 2OppenheimerBuy, maintained$52+27.2%
Nov 2Morgan StanleyBuy, maintained$52+27.2%
Oct 30D.A. DavidsonHold, maintained$43+5.2%
−1.9%average 20-day move after past Neutral readings
±3.8%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Amrize market cap and key statistics

Amrize’s market cap is $22.36B, with a P/E ratio of 18.3 and revenue of $12.26B over the last twelve months.

Valuation

Market cap
$22.36B
P/E ratio
18.3
Forward P/E
15.5
EPS, TTM
$2.23
Gekko Fair Value
$52.83

Trading

Volume
2.03M
Avg volume, 20 days
4.36M
52-week high
$65.94
52-week low
$35.78
Shares outstanding
532.4M

Financials

Revenue, TTM
$12.26B
Profit margin
10.2%
Return on equity
9.7%
Quarterly earnings growth, YoY
+4.1%

Risk and income

Typical daily move
±3.8%
Typical 20-day move
±6.4%
Dividend yield
1.06%

Amrize stock news this week

Coverage of Amrize this week reads negative: 1 positive, 1 neutral and 2 negative headlines.

News sentiment negative

Amrize peers

Amrize’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
CRHCRH−1.2%Neutral9.3% above
VMCVulcan Materials−1.3%Neutral3.7% above
MLMMartin Marietta Materials−1.4%Neutral3.3% below
JHXJames Hardie Industries0.0%Neutral2.1% above
ACAArcosa+0.2%Distribution25.1% above
EXPEagle Materials−1.5%Neutral1.7% above

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Construction materials

Amrize stock FAQ

What is Amrize’s market cap?

Amrize’s market cap is $22.36B at the Nov 13, 2026 close of $40.89, with 532.4M shares outstanding. The shares trade on a P/E ratio of 18.3.

What is the Amrize stock forecast?

The consensus analyst 12-month price target for Amrize is $45.02, +10.1% from the last close. Of the 16 firms that rated the stock in the last 90 days, 6 rate it a buy, 9 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.

Is Amrize stock overvalued or undervalued?

On Gekko’s estimate Amrize is undervalued: the Nov 13, 2026 close of $40.89 is 22.6% below Gekko Fair Value of $52.83. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Amrize report earnings next?

Amrize is expected to report on Feb 16, 2027 (93 days away). Analysts expect earnings of $0.59 per share on revenue of $2.93B. Amrize beat the earnings estimate in 0 of its last 8 reports, moving 7.2% on average across the report.

What is Amrize’s 52-week high and low?

Amrize’s 52-week high is $65.94 and its 52-week low is $35.78; it closed at $40.89 on Nov 13, 2026, −18.3% over the past year.

Is Amrize stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (fair value, smart money and earnings risk), 2 as mixed (trend and gekkoindex). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Amrize the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.